Stock listing

TPEx:6620 Handa Pharmaceuticals Inc (漢達) 股價

Follow Handa Pharmaceuticals Inc into a list and get an email when it puts out news.

Share price · TPEX:6620

$82.30 TWD -19.20 (-18.9%)

Close on Nov 20, 2026

Past year -30.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$82.30 – $89.90 TWDNov 20, 2026
Volume
2.33M sharesNov 20, 2026
Market cap
$13.38B TWDAt the close on Nov 20, 2026 · price × 162.5M shares outstanding
52-week range
$64.10 – $155.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$393.5M TWDMedian day 2.77M shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Handa Pharmaceuticals Inc logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6620 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$82.30-19.20-18.9%$89.90$89.90$82.302,334,440
$101.50-7.00-6.5%$108.50$108.50$100.502,127,486
$108.50+1.00+0.9%$103.00$110.50$102.002,598,322
$107.50-11.50-9.7%$117.00$117.50$107.502,496,931
$119.00-4.00-3.3%$118.50$125.50$114.503,263,279
$123.00-13.50-9.9%$130.00$132.00$123.003,303,200
$136.50+11.00+8.8%$132.00$137.50$126.504,981,851
$125.50+11.00+9.6%$118.50$125.50$118.505,442,498
$114.50+10.00+9.6%$104.50$114.50$102.002,380,627
$104.50+4.00+4.0%$90.50$110.50$90.506,195,882
$100.50-11.00-9.9%$100.50$100.50$100.501,785,881
$111.50-12.00-9.7%$125.00$127.00$111.503,882,677
$123.50-3.00-2.4%$125.00$129.00$118.002,377,099
$126.50-6.00-4.5%$128.00$130.00$123.501,462,946
$132.50-5.00-3.6%$135.50$137.50$130.001,663,895
$137.50+1.00+0.7%$136.50$140.50$134.001,435,860
$136.50+2.00+1.5%$135.50$140.50$133.501,501,883
$134.50-4.50-3.2%$140.00$146.00$134.502,858,164
$139.000.000.0%$139.00$139.00$139.000
$139.00+5.50+4.1%$134.50$146.00$133.503,807,373
$133.50+4.00+3.1%$132.50$133.50$129.501,537,807
$129.50-8.50-6.2%$140.50$143.50$129.502,930,126
$138.00-5.50-3.8%$142.00$145.00$135.003,727,297
$143.50+13.00+10.0%$133.50$143.50$133.505,336,202
$130.50-6.00-4.4%$134.00$141.00$130.505,678,888
$136.50+12.00+9.6%$127.50$136.50$127.502,385,522
$124.50-3.00-2.4%$126.00$129.50$124.001,114,825
$127.500.000.0%$124.00$130.00$124.00841,362
$127.50+2.50+2.0%$126.50$133.00$126.002,099,200
$125.00-8.00-6.0%$130.50$132.50$124.002,992,492
$133.00-13.00-8.9%$145.00$145.00$131.504,537,465
$146.00+2.50+1.7%$146.00$150.00$143.004,123,835
$143.50-1.00-0.7%$145.00$149.50$142.503,957,518
$144.50+3.50+2.5%$145.50$154.50$140.509,018,110
$141.00+5.00+3.7%$137.50$145.00$133.007,315,077
$136.00+12.00+9.7%$125.00$136.00$123.502,916,112
$124.00-6.00-4.6%$129.00$129.00$120.002,688,101
$130.00+3.50+2.8%$126.50$132.50$125.002,847,275
$126.50-11.00-8.0%$137.50$137.50$125.005,203,047
$137.50-11.50-7.7%$151.50$152.00$135.006,128,968
$149.00+2.00+1.4%$147.00$155.00$140.509,852,017
$147.00+13.00+9.7%$143.00$147.00$143.002,014,935
$134.00+12.00+9.8%$119.00$134.00$118.502,935,011
$122.00-5.00-3.9%$127.50$132.50$122.002,030,611
$127.00+3.00+2.4%$125.00$128.00$120.001,385,166
$124.00-2.50-2.0%$123.50$126.50$123.501,337,737
$126.50-5.50-4.2%$128.50$129.00$124.002,141,043
$132.00+8.00+6.5%$127.50$132.00$127.002,905,054
$124.00+11.00+9.7%$121.50$124.00$120.005,893,086
$113.00+5.50+5.1%$114.50$118.00$107.509,322,211
$107.50+9.50+9.7%$105.00$107.50$97.106,781,602
$98.00+2.60+2.7%$92.90$103.50$92.003,552,146
$95.40+8.60+9.9%$87.90$95.40$87.702,889,000
$86.80-6.10-6.6%$102.00$102.00$86.804,698,055
$92.90+8.40+9.9%$92.90$92.90$92.90650,000
$84.50+7.60+9.9%$77.10$84.50$77.101,189,150
$76.90+1.10+1.5%$75.80$78.20$75.80264,000
$75.80+1.20+1.6%$74.60$77.10$74.60188,002
$74.60-1.20-1.6%$75.80$75.80$74.10297,100
$75.80+0.80+1.1%$75.00$76.00$74.70159,002
$75.00-0.80-1.1%$75.50$76.60$75.00212,000
$75.80+1.00+1.3%$74.80$76.70$74.80184,000
Ticker
TPEx:6620
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
TPEx
Currency
TWD

Handa Pharmaceuticals Inc on 6ix

Sector
Health care
Industry
Pharmaceuticals

Valuation

P/E 27.3× against a median of 35.7×: 4th lowest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$9.65B TWD
P/E
27.3×
EV/sales
8.0×
EV/EBITDA
15.6×
Price/book
2.7×
Gross margin
81.4%
Operating margin
37.5%
Net margin
40.5%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Handa Pharmaceuticals Inc · TPEX:6620US$405.8MUS$292.6M27.3×8.0×15.6×2.7×40.5%0.0×n/a
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A · SSE:603811US$426.4MUS$399.3M15.0×3.2×n/a1.9×22.8%0.0×n/a
Harbin Medisan Pharmaceutical Co., Ltd. Class A · SZSE:002900US$413.1MUS$377.4Mn/a3.0×n/a1.6×−27.1%0.1×n/a
PKU Healthcare Corp. Ltd. Class A · SZSE:000788US$412.4MUS$243.9M133×1.8×n/a1.8×2.3%0.0×n/a
CorMedix Inc. · NASDAQ:CRMDUS$410.8MUS$201.0M6.4×0.5×1.0×0.9×15.5%0.3×0.71
Huaren Pharmaceutical Co., Ltd. Class A · SZSE:300110US$409.9MUS$445.4Mn/a2.4×n/a3.2×−40.2%0.5×n/a
ScinoPharm Taiwan, Ltd. · TWSE:1789US$404.2MUS$324.5M797×3.5×n/a1.3×0.5%0.1×n/a
Zhuhai Rundu Pharmaceutical Co. Ltd. Class A · SZSE:002923US$401.6MUS$381.7M47.1×1.9×n/a2.4×4.2%0.2×n/a
Cheng Du Sheng Nuo Biotec Co., Ltd. Class A · SSE:688117US$398.5MUS$406.8M12.7×2.8×n/a2.3×21.8%0.3×n/a
Kexing Biopharm Co., Ltd. Class A · SSE:688136US$398.1MUS$410.5M35.7×2.1×n/a1.5×5.7%0.4×n/a
Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A · SSE:603139US$393.1MUS$396.8Mn/a5.1×n/a3.9×−38.4%0.2×n/a
Median of the othersUS$407.1MUS$389.3M35.7×2.6×1.0×1.9×3.2%0.2×0.71

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
83.00 TWD · Analysts' mean
EPS, year to Dec 2027
5.11 · 1 analyst

Team and board

OfficerRole
Bill LiuPresident and Chief Executive Officer
Li QiaoSVP Program Management & Regulatory Affairs & COO
David QuiggleVice President – Regulatory Affairs
George KraftVice President – Corporate Development
Maggie ChangExecutive Vice President – Quality Affairs
Michael HeVice President – Product Development
Alex HuangDirector – Corporate Development

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 15, 2026 · Before open−9.7%
Q2 2026Aug 14, 2026−4.5%

Open Events

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue1.73B830.7M1.11B197.7M29.2M
Cost of revenue267.5M1.17M1.30M18.7M1.46M
Gross profit1.46B829.5M1.11B179.0M27.8M
Research and development362.6M291.9M267.3M179.8M209.0M
Selling, general and administrative165.0M119.5M144.3M87.3M72.7M
Operating income934.2M418.1M693.4M-88.1M-253.9M
Depreciation and amortization164.1M10.4M12.4M15.2M35.2M
EBITDA1.10B428.5M705.9M-72.9M-218.7M
Interest expense2.20M492.0K222.0K281.0K232.0K
Income before tax937.0M479.2M792.5M-43.1M-260.8M
Net income749.8M472.7M726.9M-40.0M-247.7M
Earnings per share, basic4.453.375.15-0.30-1.98

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents1.81B597.4M667.0M365.9M263.3M
Short-term investments1.90B1.23B1.65B2.59M33.3M
Receivables580.0M190.4M376.4M153.5M7.79M
Inventory041.2M0
Current assets4.31B2.11B2.71B592.9M314.3M
Goodwill35.9M35.9M34.9M34.9M34.9M
Total assets5.89B3.44B3.04B790.6M498.5M
Accounts payable30.2M20.8M14.0M6.22M1.08M
Current liabilities117.8M241.4M209.5M45.4M29.7M
Total liabilities232.1M324.1M280.9M69.4M35.4M
Shareholders' equity5.66B3.12B2.76B721.1M463.1M
Shares outstanding168.5M140.5M141.1M132.2M125.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations243.6M497.6M668.4M-211.6M-179.2M
Capital spending-17.1M-7.77M-944.0K-758.0K-7.15M
Free cash flow226.5M489.8M667.4M-212.3M-186.4M
Dividends paid-236.3M-141.1M
Share buybacks-57.9M-56.5M0
Change in cash1.21B-69.7M301.1M102.6M-16.8M

Open Financials

Cap table

Built by 6ix from Handa Pharmaceuticals Inc’s releases

Common shares
162,530,100
Fully diluted
162,530,100

Fully diluted

LineShares
Common shares162,530,100

Share count over time

CountShares
Nov 22, 2026162,530,100

Open Cap table

Shareholders

Register

HolderSharesOf the companyChangeAs of
Liu Handa Holdings.LLC27.3M16.4%No changeOct 31, 2026
台灣神隆股份有限公司17M10.2%No changeOct 31, 2026
Qiao Li884K0.53%No changeOct 31, 2026
張美芳528K0.32%No changeOct 31, 2026
陳俊良439K0.26%No changeOct 31, 2026
劉芳宇327K0.20%No changeOct 31, 2026
宋國峻243K0.15%No changeOct 31, 2026
楊啟余232K0.14%No changeOct 31, 2026
段宗一167K0.10%No changeOct 31, 2026
黃潤慈91,0000.05%No changeOct 31, 2026
All 20 holders
HolderSharesOf the companyChangeAs of
陳曉柔54,5000.03%No changeOct 31, 2026
馬海怡21,0000.01%No changeOct 31, 2026
周珮芬00.00%NewOct 31, 2026
盧麗安00.00%NewOct 31, 2026
徐大誠00.00%NewOct 31, 2026
吳晉00.00%NewOct 31, 2026
林衛理00.00%NewOct 31, 2026
賴麒開00.00%NewOct 31, 2026
Liu Handa Holdings.LLCNo changeNov 22, 2026
台灣神隆股份有限公司No changeNov 22, 2026

Funds

HolderSharesValueChangeAs of
State Street(R) SPDR(R) Portfolio Emerging Markets ETF62,567US$187KNo changeJun 30, 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF53,491US$160K−3,000Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alex HuangDirector – Corporate Development · Since at least Nov 5, 2026
Bill LiuPresident and Chief Executive Officer · Since at least Nov 5, 2026
David QuiggleVice President – Regulatory Affairs · Since at least Nov 5, 2026
George KraftVice President – Corporate Development · Since at least Nov 5, 2026
Li QiaoSVP Program Management & Regulatory Affairs & COO · Since at least Nov 5, 2026
Maggie ChangExecutive Vice President – Quality Affairs · Since at least Nov 5, 2026
Michael HeVice President – Product Development · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Handa Pharmaceuticals Inc.